Literature DB >> 22094872

P27/SKP-2 histochemical profile is relevant to malignant salivary gland tumors (MST) histogenesis and tumor grade.

Sharon Akrish1, Ofer Ben-Izhak, Micha Peled.   

Abstract

Malignant salivary gland tumors (MST) represent over more than 24 distinct morphological subtypes. Most high grade tumors arise from the excretory duct portion of the salivary gland apparatus; the remainder from the intercalated duct portion. Altered p27/skp-2 expression has been associated with tumor aggressiveness and histologic differentiation. In our study, we analyzed p27/skp-2 expression proteins on series of malignant salivary gland tumors in order to assess their value as a histogenetic marker, which is relevant to tumor grade. 61 MST cases were segregated by proposed histogenesis and immunohistochemistry was performed using antibodies directed against p27 and skp-2. MST of proposed intercalated duct origin (n=27) showed strong p27 expression (n=25/27; 93%) in the vast majority of cases and all cases weakly expressed skp-2. MST of proposed excretory duct origin (n=32) showed strong p27 expression (n=18/32; 56%) and moderately strong/strong skp-2 expression (n=18/32; 56%), respectively, in over half the cases. MST of intercalated duct origin showed evident p27/skp-2 inverse correlation. Differences in p27/skp-2 expression among the MST subtypes correlated with histogenesis and tumor grade, which reinforces the notion that tumor behavior is relevant to the portion of the salivary gland unit from which they arise. MST of proposed intercalated duct origin strongly expressed p27, and not skp-2, unlike MST of proposed excretory duct origin. The immunohistochemical profile of high grade mucoepidermoid carcinoma was distinct from its low/intermediate grade counterparts, suggesting a separate identity. These results may influence future decision making when formulating workable MST categorization schemes. Further studies on a larger series of MST are warranted in order to support the value of our findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094872      PMCID: PMC3370029          DOI: 10.1007/s12105-011-0309-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  33 in total

Review 1.  Salivary gland neoplasia: a review for the practicing pathologist.

Authors:  Richard J Zarbo
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

Review 2.  Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes.

Authors:  Margaret S Brandwein; Alfio Ferlito; Patrick J Bradley; Jos J Hille; Alessandra Rinaldo
Journal:  Acta Otolaryngol       Date:  2002-10       Impact factor: 1.494

3.  Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) in oral malignant tumors.

Authors:  R Ito; W Yasui; Y Ogawa; S Toyosawa; E Tahara; N Ijuhin
Journal:  Pathobiology       Date:  1999 Jul-Aug       Impact factor: 4.342

4.  Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.

Authors:  C S Choi; G Choi; K Y Jung; J O Choi; Y S Chae
Journal:  Head Neck       Date:  2001-04       Impact factor: 3.147

5.  Histogenic classification of salivary tumors.

Authors:  L R Eversole
Journal:  Arch Pathol       Date:  1971-12

6.  Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression.

Authors:  S E Dowen; A Scott; G Mukherjee; M A Stanley
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

7.  Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.

Authors:  Atsuko Hara; Isao Okayasu
Journal:  Acta Neuropathol       Date:  2004-04-16       Impact factor: 17.088

8.  Immunohistochemical distinction of high-grade mucoepidermoid carcinoma and epidermoid carcinoma of the parotid region.

Authors:  A P V Sobral; S V L Loducca; L P Kowalski; I R B Santos; O P Almeida; N S Araújo; V C Araújo
Journal:  Oral Oncol       Date:  2002-07       Impact factor: 5.337

Review 9.  Salivary gland tumours.

Authors:  P M Speight; A W Barrett
Journal:  Oral Dis       Date:  2002-09       Impact factor: 3.511

10.  Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis.

Authors:  Sharon Akrish; Micha Peled; Ofer Ben-Izhak; Rafi M Nagler
Journal:  Oral Oncol       Date:  2009-09-02       Impact factor: 5.337

View more
  3 in total

1.  Evaluation of p27 Expression in Salivary Gland Neoplasms; A Step Forward in Unveiling the Role of p27.

Authors:  Nikhil I Malgaonkar; Abdulwahab Abuderman; M Y Kharma; S A Al-Maweri; N A Alaizari; Ma Altamimi; S Darwish; Bassel Tarakji
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.

Authors:  Bin Zhang; Lin-Hua Ji; Wei Liu; Gang Zhao; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  P27 expression in pleomorphic salivary gland adenoma.

Authors:  Bassel Tarakji; Ayesha Umair; Mohammed Alsakran Altamimi; Saleh Nasser Azzeghaiby; Abla Sayed Mahmoud; Shourouk Darwish; Mohammad Zakaria Nassani; Nipun Ashok
Journal:  Contemp Oncol (Pozn)       Date:  2014-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.